| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701084 | European Journal of Surgical Oncology (EJSO) | 2017 | 8 Pages |
Abstract
SBRT seems to be an effective and safe therapeutic option for isolated local recurrence of pancreatic cancer after surgery. Encouraging local control rate, very low toxicity profile and effective pain control suggest the crucial role of SBRT in the treatment of these long-survivors selected patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
T. Comito, L. Cozzi, A. Zerbi, C. Franzese, E. Clerici, A. Tozzi, C. Iftode, P. Navarria, G. D'Agostino, A. Fogliata, P. Mancosu, S. Tomatis, C. Carnaghi, N. Personeni, A. Santoro, M. Scorsetti,